🞩
About
Our Science
How We Think Bioisosterism Chemical Diversity Solutions
Discovery Services
Medicinal Chemistry MedChem Enabling Platforms Route Scouting Fee for Service Consulting
Products
Catalog Structure Search
Libraries
DEL-compatible scaffolds and capping agents 3D Scaffolds Macrocycle Library Covalent Fragments Fragments SpiroSpaceTM
SpiroKits
SPK1: pKa-Tuned Amines SPK2: sp2 to sp3 Switch SPK3: Constrained N-Boc Amino Acids SPK4: Azaspiro[3.3]heptane derivatives SPK5: Bicyclic diamines SPK6: Constrained Amino Alcohols SPK7: Bicyclic amino ketones SPK8: Constrained N-Fmoc amino acids
News Publications Careers Contact
icon
icon
icon
icon
icon

SpiroChem AG:
Rosental area, WRO-1047-3
Mattenstrasse 22
4058 Basel, Switzerland

Tel: + 41 61 685 95 00
E-mail: contact@spirochem.com

icon

Swiss Discovery Sciences

🞩

Search by SPC, Chemical Name, CAS or keyword

Chemistry News

Press Release

Chemistry for breakfast, lunch, and dinner… Interview with Thomas Fessard, SpiroChem’s CEO
Press Release

Chemistry for breakfast, lunch, and dinner… Interview with T...

Nov 03 2021

SpiroChem’s CEO, Thomas Fessard, shares his vast knowledge in the field of synthetic chemistry and entrepreneurship with BaseLaunch participants. See ...
Celebrating 10 years of SpiroChem
Press Release

Jun 04 2021

Celebrating 10 years of SpiroChem

SpiroChem sponsors two postdocs and one PhD student in Prof. Sarlah’s academic group
Press Release

Feb 12 2021

SpiroChem sponsors two postdocs and one PhD student in Prof. Sarlah’s academic group

Exploration of linker and bioisostere technology and application to ADCs
Press Release

Dec 01 2020

Exploration of linker and bioisostere technology and application to ADCs

SpiroChem joins BaseLaunch as Domain Partner
Press Release

Oct 28 2020

SpiroChem joins BaseLaunch as Domain Partner

Artificial Intelligence platforms to increase innovation and speed in drug discovery
Press Release

Sep 18 2020

Artificial Intelligence platforms to increase innovation and speed in drug discovery

SpiroChem and Domainex enter a fragment drug discovery partnership.
Press Release

Mar 20 2019

SpiroChem and Domainex enter a fragment drug discovery partnership.

A word from Dr. Thomas Fessard, CEO @ SpiroChem.
Press Release

Aug 21 2018

A word from Dr. Thomas Fessard, CEO @ SpiroChem.

Annual Summary 2017 - On track for ambitious growth path.
Press Release

Mar 05 2018

Annual Summary 2017 - On track for ambitious growth path.

SpiroChem AG successfully completes fundraise to support accelerated growth.
Press Release

Dec 13 2017

SpiroChem AG successfully completes fundraise to support accelerated growth.

Newsletter

Don’t miss out on what is important.

Let us inspire you. Subscribe now to keep updated on new concepts, products, solutions & more.

web by kara5